Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1864 (LINC01864) is a non-coding RNA gene located in intergenic genomic regions and transcribed into long RNA molecules (>200 nucleotides) that do not code for proteins. LINC01864, like other lincRNAs, is thought to play roles in regulating expression of neighboring genes, remodeling chromatin, stabilizing RNA, and regulating transcription in a tissue-specific manner. Though the specific biological function of LINC01864 remains uncharacterized, recent studies have used it as part of a lncRNA panel for distinguishing cancer from normal tissue, indicating potential roles in disease as a biomarker. LINC01864 is not a conventional therapeutic target such as a receptor, enzyme, transporter, or transcription factor, but may serve as a molecular biomarker in oncology research; no known drugs currently target it directly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1864 (LINC01864).